Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Plos One
|
May 7, 2019
Is insulin resistance the cause of fibromyalgia? A preliminary report
Miguel A Pappolla, Laxmaiah Manchikanti, Clark R Andersen, et al.
Journal of Neurochemistry
|
September 2, 2005
Mitochondrial medicine: neuroprotection and life extension by the new amphiphilic nitrone LPBNAH acting as a highly potent antioxidant agent
Burkhard Poeggeler, Grégory Durand, Ange Polidori, et al.
Journal of Clinical Medicine
|
December 30, 2025
Pharmacologic and Nonpharmacologic Pain Management in Patients with Traumatic Brain Injury: A Multidisciplinary Approach
Benjamin S Esneault, Macie B Maddox, Ethan M Loewe, et al.
Current Alzheimer Research
|
December 20, 2014
Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease
Robert J Baranello, Krishna L Bharani, Vasudevaraju Padmaraju, et al.
Pain Physician
|
March 19, 2021
Insulin Resistance is Associated with Central Pain in Patients with Fibromyalgia
Miguel A Pappolla, Laxmaiah Manchikanti, Kenneth D Candido, et al.
Pain Physician
|
April 1, 2025
Efficacy of Nerve Blocks for Managing Refractory Posttraumatic Headaches
Christopher File, Xiang Fang, Rowaid Ahmad, et al.
Free Radical Biology & Medicine
|
July 11, 2002
Cholesterol, oxidative stress, and Alzheimer's disease: expanding the horizons of pathogenesis
Miguel A Pappolla, Mark A Smith, Tara Bryant-Thomas, et al.
Neurobiology of Disease
|
March 7, 2006
Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid beta peptide levels
Javier Pacheco-Quinto, Elena B Rodriguez de Turco, Steven DeRosa, et al.
Pain Physician
|
December 5, 2018
Do Regenerative Medicine Therapies Provide Long-Term Relief in Chronic Low Back Pain: A Systematic Review and Metaanalysis
Jaya Sanapati, Laxmaiah Manchikanti, Sairam Atluri, et al.
Journal of Neurochemistry
|
February 16, 2011
Targets for AD treatment: conflicting messages from γ-secretase inhibitors
Kumar Sambamurti, Nigel H Greig, Tadanobu Utsuki, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Plos One
|
May 7, 2019
Is insulin resistance the cause of fibromyalgia? A preliminary report
Miguel A Pappolla, Laxmaiah Manchikanti, Clark R Andersen, et al.
Journal of Neurochemistry
|
September 2, 2005
Mitochondrial medicine: neuroprotection and life extension by the new amphiphilic nitrone LPBNAH acting as a highly potent antioxidant agent
Burkhard Poeggeler, Grégory Durand, Ange Polidori, et al.
Journal of Clinical Medicine
|
December 30, 2025
Pharmacologic and Nonpharmacologic Pain Management in Patients with Traumatic Brain Injury: A Multidisciplinary Approach
Benjamin S Esneault, Macie B Maddox, Ethan M Loewe, et al.
Current Alzheimer Research
|
December 20, 2014
Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease
Robert J Baranello, Krishna L Bharani, Vasudevaraju Padmaraju, et al.
Pain Physician
|
March 19, 2021
Insulin Resistance is Associated with Central Pain in Patients with Fibromyalgia
Miguel A Pappolla, Laxmaiah Manchikanti, Kenneth D Candido, et al.
Pain Physician
|
April 1, 2025
Efficacy of Nerve Blocks for Managing Refractory Posttraumatic Headaches
Christopher File, Xiang Fang, Rowaid Ahmad, et al.
Free Radical Biology & Medicine
|
July 11, 2002
Cholesterol, oxidative stress, and Alzheimer's disease: expanding the horizons of pathogenesis
Miguel A Pappolla, Mark A Smith, Tara Bryant-Thomas, et al.
Neurobiology of Disease
|
March 7, 2006
Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid beta peptide levels
Javier Pacheco-Quinto, Elena B Rodriguez de Turco, Steven DeRosa, et al.
Pain Physician
|
December 5, 2018
Do Regenerative Medicine Therapies Provide Long-Term Relief in Chronic Low Back Pain: A Systematic Review and Metaanalysis
Jaya Sanapati, Laxmaiah Manchikanti, Sairam Atluri, et al.
Journal of Neurochemistry
|
February 16, 2011
Targets for AD treatment: conflicting messages from γ-secretase inhibitors
Kumar Sambamurti, Nigel H Greig, Tadanobu Utsuki, et al.
Page
of 5